Laddar...
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
BACKGROUND: The expression of HER2, estrogen (ER) and progesterone (PR) receptor can change during the course of the disease in breast cancer (BC). Therefore, reassessment of these markers at the time of disease progression might help to optimize treatment decisions. In this context, characterizatio...
Sparad:
| I publikationen: | BMC Cancer |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4960681/ https://ncbi.nlm.nih.gov/pubmed/27456970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2587-4 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|